MiR-93 expression is upregulated in PCOS-GCs, and its predicted target, cyclin-dependent kinase inhibitor 1A (CDKN1A), is suppressed in PCOS-GCs [42]. The gene discussed is CDKN1A; the disease is polycystic ovary syndrome.